Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma: A BEACON-Neuroblastoma biomarker study.

Moreno, L, Weston, R, Viprey, V et al. (17 more authors) (2022) Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma: A BEACON-Neuroblastoma biomarker study. In: 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, 03-07 Jun 2022, Chicago, USA & Online.

Metadata

Authors/Creators:
  • Moreno, L
  • Weston, R
  • Viprey, V
  • Tchirkov, A
  • Corrias, M
  • Lammens, T
  • Gray, J
  • Owens, C
  • Laidler, J
  • Gambart, M
  • Castel, V
  • Van Eijkelenburg, N
  • Nysom, K
  • Laureys, G
  • Castellano, A
  • Gerber, NU
  • Ladenstein, RL
  • Couanet, DV
  • Wheatley, K
  • Burchill, SA ORCID logo https://orcid.org/0000-0002-1034-3723
Dates:
  • Published: 1 June 2022
Institution: The University of Leeds
Funding Information:
FunderGrant number
Solving Kids' Cancer EuropeNo EXT Ref
Depositing User: Symplectic Publications
Date Deposited: 18 Nov 2022 14:25
Last Modified: 18 Nov 2022 14:25
Status: Published
Identification Number: https://doi.org/10.1200/JCO.2022.40.16
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)